HOME >> BIOLOGY >> NEWS
Alejandro Zaffaroni to receive 2006 Biotechnology Heritage Award

The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) will present the 8th Annual Biotechnology Heritage Award to Alejandro Zaffaroni, an outstanding pioneer of the biotechnology revolution and legendary entrepreneur with considerable scientific and business skills. The award will be presented at the plenary breakfast session from 7:30 to 9:00 a.m. on Monday, 10 April, at BIO 2006 at McCormick Place Convention Center in Chicago.

"Dr. Zaffaroni's scientific contributions, particularly in the area of drug delivery, have enhanced health care for people throughout the world," stated BIO president Jim Greenwood. "His steadfast commitment to research and development has earned him more than two dozen patents and the deep-founded respect of his colleagues."

"Alex Zaffaroni helped to guide Syntex to success in the 1950's, and has gone on to give the world a half-century of life-saving innovations through his commitment to novel drug delivery and his inspired entrepreneurship," said Arnold Thackray, president of CHF. "He embodies the spirit that is making biotechnology a living, thriving reality."

Alejandro Zaffaroni
Over a long and distinguished career, Zaffaroni has founded and cofounded many companies that have become world leaders in medical technology. A native of Montevideo, Uruguay, Zaffaroni joined Syntex Corporation in 1951. At the time, Syntex was a small chemical company in Mexico that was becoming prominent in steroid research. He subsequently played a key role in transforming Syntex into a major pharmaceutical company that pioneered the development of the birth control pill.

Zaffaroni developed controlled drug delivery technology, more commonly known as "the patch," and founded ALZA Corporation to bring this important technology to the world market. In addition to ALZA, Zaffaroni founded DNAX, Affymax, Affymetrix, Maxygen, SurroMed, and Alexza--all companies that developed and mar
'"/>

Contact: Neil Gussman
neilg@chemheritage.org
215-873-8262
Chemical Heritage Foundation
24-Apr-2006


Page: 1 2

Related biology news :

1. Carnegie Mellons Peter Adams receives EPA research grant
2. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
3. Fedoroff, of Penn State, to receive National Medal of Science
4. Philadelphia ecologist receives top Mongolia honor
5. Nearly 90 percent of babies receive recommended newborn screening tests
6. VIB scientist receives major research grant
7. Maynard Olson receives $500,000 Gruber Genetics Prize
8. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
9. UGA scientists receive $20M in federal bioenergy initiative
10. Wright State scientist receives grant to help clean up polluted American harbors
11. UCR biologist receives $1.75 million grant to study plant-threatening bacteria

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alejandro Zaffaroni receive Biotechnology Heritage Award

(Date:4/17/2014)... One day about eight years ago, Katia Silvera ... and her father were on a field trip in a ... orchid they had never seen before. , Unable to identify ... The orchid turned out to be an unnamed species. ... silverarum . , "Lophiaris" is the genus name, comprising about ...
(Date:4/17/2014)... France have hit on a novel method to ... correct and most effective treatment possible., Kidney stones ... and developing world. If left untreated, apart from ... failure and other complications. In many patients treated ... a more effective pathological approach to diagnosis and ...
(Date:4/17/2014)... expression is the process whereby the genetic information ... such as proteins, which have numerous different functions ... an important intermediary during gene expression, by relating ... mechanisms involved in manufacturing proteins. , By ... molecules present in an organism at a given ...
Breaking Biology News(10 mins):Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3Rapid and accurate mRNA detection in plant tissues 2
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
Cached News: